About Us Services Careers FAQ Contact Us 0
Home Medical Devices Sepsis Diagnostics Market Size, Trends and Growth Analysis | 2031
Sepsis Diagnostics Market

Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Blood Culture Media, Assay Kits and Reagents, Software), By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry), By Pathogen (Bacterial Sepsis, Gram Positive, Gram Negative, Fungal Sepsis, Others), By Testing Type (Laboratory Testing, Point-of-Care Testing) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRMD1152DR
Last Updated : February 27, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Sepsis Diagnostics Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Blood Culture Media
        1. By Value
      4. Assay Kits and Reagents
        1. By Value
      5. Software
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Microbiology
        1. By Value
      3. Molecular Diagnostics
        1. By Value
      4. Immunoassays
        1. By Value
      5. Flow Cytometry
        1. By Value
    4. By Pathogen
      1. Introduction
        1. Pathogen By Value
      2. Bacterial Sepsis
        1. By Value
      3. Gram Positive
        1. By Value
      4. Gram Negative
        1. By Value
      5. Fungal Sepsis
        1. By Value
      6. Others
        1. By Value
    5. By Testing Type
      1. Introduction
        1. Testing Type By Value
      2. Laboratory Testing
        1. By Value
      3. Point-of-Care Testing
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Blood Culture Media
        1. By Value
      4. Assay Kits and Reagents
        1. By Value
      5. Software
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Microbiology
        1. By Value
      3. Molecular Diagnostics
        1. By Value
      4. Immunoassays
        1. By Value
      5. Flow Cytometry
        1. By Value
    4. By Pathogen
      1. Introduction
        1. Pathogen By Value
      2. Bacterial Sepsis
        1. By Value
      3. Gram Positive
        1. By Value
      4. Gram Negative
        1. By Value
      5. Fungal Sepsis
        1. By Value
      6. Others
        1. By Value
    5. By Testing Type
      1. Introduction
        1. Testing Type By Value
      2. Laboratory Testing
        1. By Value
      3. Point-of-Care Testing
        1. By Value
    6. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Blood Culture Media
          1. By Value
        4. Assay Kits and Reagents
          1. By Value
        5. Software
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Microbiology
          1. By Value
        3. Molecular Diagnostics
          1. By Value
        4. Immunoassays
          1. By Value
        5. Flow Cytometry
          1. By Value
      3. By Pathogen
        1. Introduction
          1. Pathogen By Value
        2. Bacterial Sepsis
          1. By Value
        3. Gram Positive
          1. By Value
        4. Gram Negative
          1. By Value
        5. Fungal Sepsis
          1. By Value
        6. Others
          1. By Value
      4. By Testing Type
        1. Introduction
          1. Testing Type By Value
        2. Laboratory Testing
          1. By Value
        3. Point-of-Care Testing
          1. By Value
    7. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Blood Culture Media
        1. By Value
      4. Assay Kits and Reagents
        1. By Value
      5. Software
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Microbiology
        1. By Value
      3. Molecular Diagnostics
        1. By Value
      4. Immunoassays
        1. By Value
      5. Flow Cytometry
        1. By Value
    4. By Pathogen
      1. Introduction
        1. Pathogen By Value
      2. Bacterial Sepsis
        1. By Value
      3. Gram Positive
        1. By Value
      4. Gram Negative
        1. By Value
      5. Fungal Sepsis
        1. By Value
      6. Others
        1. By Value
    5. By Testing Type
      1. Introduction
        1. Testing Type By Value
      2. Laboratory Testing
        1. By Value
      3. Point-of-Care Testing
        1. By Value
    6. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Blood Culture Media
          1. By Value
        4. Assay Kits and Reagents
          1. By Value
        5. Software
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Microbiology
          1. By Value
        3. Molecular Diagnostics
          1. By Value
        4. Immunoassays
          1. By Value
        5. Flow Cytometry
          1. By Value
      3. By Pathogen
        1. Introduction
          1. Pathogen By Value
        2. Bacterial Sepsis
          1. By Value
        3. Gram Positive
          1. By Value
        4. Gram Negative
          1. By Value
        5. Fungal Sepsis
          1. By Value
        6. Others
          1. By Value
      4. By Testing Type
        1. Introduction
          1. Testing Type By Value
        2. Laboratory Testing
          1. By Value
        3. Point-of-Care Testing
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Blood Culture Media
        1. By Value
      4. Assay Kits and Reagents
        1. By Value
      5. Software
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Microbiology
        1. By Value
      3. Molecular Diagnostics
        1. By Value
      4. Immunoassays
        1. By Value
      5. Flow Cytometry
        1. By Value
    4. By Pathogen
      1. Introduction
        1. Pathogen By Value
      2. Bacterial Sepsis
        1. By Value
      3. Gram Positive
        1. By Value
      4. Gram Negative
        1. By Value
      5. Fungal Sepsis
        1. By Value
      6. Others
        1. By Value
    5. By Testing Type
      1. Introduction
        1. Testing Type By Value
      2. Laboratory Testing
        1. By Value
      3. Point-of-Care Testing
        1. By Value
    6. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Blood Culture Media
          1. By Value
        4. Assay Kits and Reagents
          1. By Value
        5. Software
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Microbiology
          1. By Value
        3. Molecular Diagnostics
          1. By Value
        4. Immunoassays
          1. By Value
        5. Flow Cytometry
          1. By Value
      3. By Pathogen
        1. Introduction
          1. Pathogen By Value
        2. Bacterial Sepsis
          1. By Value
        3. Gram Positive
          1. By Value
        4. Gram Negative
          1. By Value
        5. Fungal Sepsis
          1. By Value
        6. Others
          1. By Value
      4. By Testing Type
        1. Introduction
          1. Testing Type By Value
        2. Laboratory Testing
          1. By Value
        3. Point-of-Care Testing
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Blood Culture Media
        1. By Value
      4. Assay Kits and Reagents
        1. By Value
      5. Software
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Microbiology
        1. By Value
      3. Molecular Diagnostics
        1. By Value
      4. Immunoassays
        1. By Value
      5. Flow Cytometry
        1. By Value
    4. By Pathogen
      1. Introduction
        1. Pathogen By Value
      2. Bacterial Sepsis
        1. By Value
      3. Gram Positive
        1. By Value
      4. Gram Negative
        1. By Value
      5. Fungal Sepsis
        1. By Value
      6. Others
        1. By Value
    5. By Testing Type
      1. Introduction
        1. Testing Type By Value
      2. Laboratory Testing
        1. By Value
      3. Point-of-Care Testing
        1. By Value
    6. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Blood Culture Media
          1. By Value
        4. Assay Kits and Reagents
          1. By Value
        5. Software
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Microbiology
          1. By Value
        3. Molecular Diagnostics
          1. By Value
        4. Immunoassays
          1. By Value
        5. Flow Cytometry
          1. By Value
      3. By Pathogen
        1. Introduction
          1. Pathogen By Value
        2. Bacterial Sepsis
          1. By Value
        3. Gram Positive
          1. By Value
        4. Gram Negative
          1. By Value
        5. Fungal Sepsis
          1. By Value
        6. Others
          1. By Value
      4. By Testing Type
        1. Introduction
          1. Testing Type By Value
        2. Laboratory Testing
          1. By Value
        3. Point-of-Care Testing
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Blood Culture Media
        1. By Value
      4. Assay Kits and Reagents
        1. By Value
      5. Software
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Microbiology
        1. By Value
      3. Molecular Diagnostics
        1. By Value
      4. Immunoassays
        1. By Value
      5. Flow Cytometry
        1. By Value
    4. By Pathogen
      1. Introduction
        1. Pathogen By Value
      2. Bacterial Sepsis
        1. By Value
      3. Gram Positive
        1. By Value
      4. Gram Negative
        1. By Value
      5. Fungal Sepsis
        1. By Value
      6. Others
        1. By Value
    5. By Testing Type
      1. Introduction
        1. Testing Type By Value
      2. Laboratory Testing
        1. By Value
      3. Point-of-Care Testing
        1. By Value
    6. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Blood Culture Media
          1. By Value
        4. Assay Kits and Reagents
          1. By Value
        5. Software
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Microbiology
          1. By Value
        3. Molecular Diagnostics
          1. By Value
        4. Immunoassays
          1. By Value
        5. Flow Cytometry
          1. By Value
      3. By Pathogen
        1. Introduction
          1. Pathogen By Value
        2. Bacterial Sepsis
          1. By Value
        3. Gram Positive
          1. By Value
        4. Gram Negative
          1. By Value
        5. Fungal Sepsis
          1. By Value
        6. Others
          1. By Value
      4. By Testing Type
        1. Introduction
          1. Testing Type By Value
        2. Laboratory Testing
          1. By Value
        3. Point-of-Care Testing
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Sepsis Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Becton
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Dickinson and Company
    3. biomérieux SA
    4. F. Hoffmann-La Roche
    5. Beckman Coulter Inc.
    6. Koninklijke Philips N.V.
    7. Wolters Kluwer N.V.
    8. Thermo Fisher Scientific Inc.
    9. Cepheid
    10. Amara Health Analytics
    11. Bruker Corporation
    12. Luminex Corporation
    13. Cerner Corporation
    14. Epic Systems Corporation
    15. McKesson Corporation
    16. GE Healthcare
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global companion diagnostics market size was valued at USD 5.37 billion in 2023. It is estimated to reach USD 15.87 billion by 2032, growing at a CAGR of 12.8% during the forecast period (2024–2032). The growing prevalence of chronic diseas
Buy Now
Global Report
Rare Disease Diagnostics Market Size The global rare disease diagnostics market size was valued at USD 1,152.35 million in 2024 and is projected to reach from USD 1,312.86 million in 2025 to USD 3,726.57 million by 2033, growing at a CAGR of 14.30%
Buy Now
Global Report
Remote Diagnostics Market Size & Trends The global remote diagnostics market size was valued at USD 41.3 billion in 2023. It is expected to reach USD 121.3 billion by 2032, growing at a CAGR of 31.8% during the forecast period (2024–20
Buy Now
Global Report
TB Diagnostics Market Size & Trends The global TB diagnostics market size was valued at USD 1.33 billion in 2021 and it is projected to reach a valuation of USD 2.14 billion by 2030 growing at a CAGR of 5.56% during the forecast period (2022–203
Buy Now
Global Report
The global transplant diagnostics market size was valued at USD 3,550 million in 2019 and is expected to grow with a CAGR of 7.4% during the forecast period, 2020–2029. Organ transplantation is a surgical procedure of removing healthy org
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.